<p><h1>Drug Eluting Balloon for Peripheral Artery Disease Market Research Report Forecasted for Period from 2023 -  2030 by Market Type, Market Application, and Region</h1></p><p><strong>Drug Eluting Balloon for Peripheral Artery Disease Market Analysis and Latest Trends</strong></p>
<p><p>A drug eluting balloon (DEB) for peripheral artery disease (PAD) is a medical device used in the treatment of blood vessel blockages in peripheral arteries. It is designed to deliver medication directly to the affected area during angioplasty, a procedure that opens up the narrowed or blocked artery.</p><p>The market analysis of the drug eluting balloon for PAD indicates significant growth potential. The increasing prevalence of PAD, particularly in the aging population, is one of the major factors driving market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 8.5 million people in the United States have PAD. Moreover, advancements in medical technology have led to the development of innovative drug eluting balloons, further propelling market growth.</p><p>In terms of market trends, there is a growing focus on improving the efficacy and safety of drug eluting balloons. Manufacturers are investing in research and development to enhance drug delivery capabilities, reduce restenosis rates (re-narrowing of arteries), and minimize adverse events. Additionally, there is a rising preference for minimally invasive procedures, which has fueled the adoption of drug eluting balloons over traditional treatment methods.</p><p>The COVID-19 pandemic has also impacted the drug eluting balloon for PAD market. The temporary suspension of elective procedures in various countries to tackle the healthcare crisis has resulted in a decline in market growth. However, as healthcare systems start to normalize, the market is expected to recover.</p><p>Overall, the drug eluting balloon for PAD market is projected to witness a compound annual growth rate (CAGR) of 7.9% during the forecast period. The increasing prevalence of PAD, technological advancements, and a preference for minimally invasive procedures are expected to drive market growth in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1671438">https://www.reliableresearchreports.com/enquiry/request-sample/1671438</a></strong></p>
<p>&nbsp;</p>
<p><strong>Drug Eluting Balloon for Peripheral Artery Disease Major Market Players</strong></p>
<p><p>The global market for drug-eluting balloons (DEBs) used in the treatment of peripheral artery disease (PAD) is highly competitive, with several key players dominating the market. Among these players are Cook Group, Bayer, BD, Medtronic, and Opto Circuits.</p><p>Cook Group, founded in 1963, is a leading global medical device manufacturer and has a strong presence in the DEB market. The company specializes in catheter-based medical devices and introduced its own drug-eluting balloon, the Advance Catheter, in 2011. Cook has a well-established reputation in the market and has experienced steady growth in recent years due to its innovative product offerings.</p><p>Bayer is a multinational pharmaceutical company that entered the DEB market through its acquisition of Possis Medical in 2008. Bayer's DEB product, the AngioSculpt, has gained significant market share and is known for its unique scoring technology. The company has a strong global presence and has seen consistent growth in revenue within the DEB market.</p><p>BD (Becton, Dickinson and Company) is a global medical technology company that offers a diverse range of medical devices, including drug-eluting balloons. BD entered the DEB market through its acquisition of C.R. Bard in 2017. The company's DEB product, the Lutonix, has gained recognition for its efficacy in treating PAD and has contributed to BD's growth in the market.</p><p>Medtronic, a leading medical technology company, entered the DEB market through its acquisition of Covidien in 2015. The company's DEB product, the In.Pact Admiral, has become a market leader and is known for its long-term efficacy in treating PAD. Medtronic has a strong global presence and has experienced significant growth in revenue within the DEB market.</p><p>Opto Circuits is an Indian medical device company that has established a presence in the DEB market with its product, the Cardiomax. The company has experienced moderate growth in the market and primarily focuses on the Indian and European markets.</p><p>While specific sales revenue figures for these companies are not provided, it is important to note that the global DEB market is estimated to be worth several hundred million dollars and is expected to experience substantial growth in the coming years. Factors such as increasing prevalence of peripheral artery disease, advancements in medical technology, and rising geriatric population are expected to drive market growth. Additionally, the demand for minimally invasive procedures and an increasing focus on reducing healthcare costs are contributing to the adoption of DEBs for PAD treatment.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug Eluting Balloon for Peripheral Artery Disease Manufacturers?</strong></p>
<p><p>The Drug Eluting Balloon (DEB) market for Peripheral Artery Disease (PAD) has been experiencing significant growth in recent years. This growth can be attributed to the increasing prevalence of PAD and the rising demand for minimally invasive treatment options. DEBs offer advantages over traditional treatment methods, as they provide sustained drug release to prevent restenosis and improve long-term outcomes. Additionally, technological advancements and the introduction of innovative products are expected to further drive market growth. Looking ahead, the DEB market for PAD is expected to continue witnessing positive growth trends, with a focus on improving patient outcomes and expanding the availability of these devices globally.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1671438">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1671438</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug Eluting Balloon for Peripheral Artery Disease Market Analysis by types is segmented into:</strong></p>
<p><ul><li>3μg/ mm2</li><li>2μg/ mm2</li><li>Others</li></ul></p>
<p><p>The Drug Eluting Balloon (DEB) for Peripheral Artery Disease (PAD) market offers different options in terms of drug concentration on the balloon's surface. The market includes three main types: 3μg/mm2, 2μg/mm2, and others. These measurements refer to the amount of drug coated on each square millimeter of the balloon's surface. The higher the concentration (3μg/mm2), the more drug is delivered during the angioplasty procedure to treat PAD. The other types may have different drug concentrations or variations that are not specifically categorized.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1671438">https://www.reliableresearchreports.com/purchase/1671438</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Drug Eluting Balloon for Peripheral Artery Disease Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Ambulatory Surgery Centers</li><li>Catheterization Laboratories</li><li>Others</li></ul></p>
<p><p>The drug-eluting balloon for peripheral artery disease is used in various medical settings like hospitals, ambulatory surgery centers, catheterization laboratories, and other healthcare facilities. In hospitals, these balloons are employed to treat peripheral artery disease, a condition that narrows the arteries in the legs, causing reduced blood flow. Ambulatory surgery centers also utilize this technology to non-surgically open blocked blood vessels. Catheterization laboratories perform procedures using these balloons to treat narrowed arteries. Other healthcare facilities may utilize these balloons for similar purposes in treating peripheral artery disease.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug Eluting Balloon for Peripheral Artery Disease Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The drug eluting balloon (DEB) market for peripheral artery disease (PAD) is poised to witness significant growth across various regions, including North America, APAC, Europe, the United States, and China. These regions show promising potential for market expansion due to the growing prevalence of peripheral artery disease and increasing awareness of DEB treatment options. The United States and Europe are expected to dominate the market, capturing a substantial market share percentage valuation. However, China and the APAC region are projected to experience rapid growth, contributing to the overall market expansion. Further analysis is necessary to determine the exact market share percentage valuation for each region.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1671438">https://www.reliableresearchreports.com/purchase/1671438</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1671438">https://www.reliableresearchreports.com/enquiry/request-sample/1671438</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@jarredmertz2772/drugs-for-amino-acid-metabolism-market-size-reveals-the-best-marketing-channels-in-global-industry-77fadbf12e31">Drugs for Amino Acid Metabolism Market</a></p><p><a href="https://www.linkedin.com/pulse/portable-veterinary-ultrasound-system-market-research-report-veiic/">Portable Veterinary Ultrasound System Market</a></p><p><a href="https://medium.com/@reyeshowell655/amino-acid-metabolism-disease-market-size-market-outlook-and-market-forecast-2023-to-2030-71f267d513a2">Amino Acid Metabolism Disease Market</a></p><p><a href="https://github.com/Krish2023na/Market-Research-Report-List-1/blob/main/automobile-fuel-meter-market.md">Automobile Fuel Meter Market</a></p><p><a href="https://www.linkedin.com/pulse/medical-resin-market-research-report-unlocks-analysis-kxgnf/">Medical Resin Market</a></p></p>